A Proteomic Study on the Personalized Protein Corona of Liposomes. Relevance for Early Diagnosis of Pancreatic DUCTAL Adenocarcinoma and Biomarker Detection
Open Access
- 11 June 2021
- journal article
- research article
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 2 (2) , 82-93
Abstract
Due to late diagnosis, high incidence of metastasis, and poor survival rate, pancreatic cancer is one of the most leading cause of cancer-related death. Although manifold recent efforts have been done to achieve an early diagnosis of pancreatic cancer, CA-19.9 is currently the unique biomarker that is adopted for the detection, despite its limits in terms of sensitivity and specificity. To identify potential protein biomarkers for pancreatic ductal adenocarcinoma (PDAC), we used three model liposomes as nanoplatforms that accumulate proteins from human plasma and studied the composition of this biomolecular layer, which is known as protein corona. Indeed, plasma proteins adsorb on nanoparticle surface according to their abundance and affinity to the employed nanomaterial, thus even small differences between healthy and PDAC protein expression levels can be, in principle, detected. By mass spectrometry experiments, we quantified such differences and identified possible biomarkers for PDAC. Some of them are already known to exhibit different expressions in PDAC proteomes, whereas the role of other relevant proteins is still not clear. Therefore, we predict that the employment of nanomaterials and their protein corona may represent a useful tool to amplify the detection sensitivity of cancer biomarkers, which may be used for the early diagnosis of PDAC, with clinical implication for the subsequent therapy in the context of personalized medicine.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (ID 20327)
This publication has 22 references indexed in Scilit:
- Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s DiseaseACS Nano, 2021
- Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer PatientsFrontiers in Bioengineering and Biotechnology, 2020
- Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammationNanoscale, 2020
- Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinomaCancer Letters, 2020
- Disease-specific protein corona sensor arrays may have disease detection capacityNanoscale Horizons, 2019
- An apolipoprotein-enriched biomolecular corona switches the cellular uptake mechanism and trafficking pathway of lipid nanoparticlesNanoscale, 2017
- Personalized protein corona on nanoparticles and its clinical implicationsBiomaterials Science, 2017
- Rapid formation of plasma protein corona critically affects nanoparticle pathophysiologyNature Nanotechnology, 2013
- Biomolecular coronas provide the biological identity of nanosized materialsNature Nanotechnology, 2012
- Understanding and controlling the interaction of nanomaterials with proteins in a physiological environmentChemical Society Reviews, 2011